0001209191-21-008138.txt : 20210205
0001209191-21-008138.hdr.sgml : 20210205
20210205165412
ACCESSION NUMBER: 0001209191-21-008138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210204
FILED AS OF DATE: 20210205
DATE AS OF CHANGE: 20210205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEONHARDT HARRY J
CENTRAL INDEX KEY: 0001286102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39376
FILM NUMBER: 21596806
MAIL ADDRESS:
STREET 1: C/O HALOZYME THERAPEUTICS, INC.
STREET 2: 11388 SORRENTO VALLEY BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Poseida Therapeutics, Inc.
CENTRAL INDEX KEY: 0001661460
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 472846548
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-779-3100
MAIL ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-04
0
0001661460
Poseida Therapeutics, Inc.
PSTX
0001286102
LEONHARDT HARRY J
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTRE DRIVE, SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
GC & Chief Compliance Officer
Employee Stock Option (Right to Buy)
9.15
2021-02-04
4
A
0
137000
0.00
A
2031-02-03
Common Stock
137000
137000
D
12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.
/s/ Johanna Mylet, Attorney-in-Fact
2021-02-05